Steven Cobourn
Director of Finance/CFO bei NEXTCURE, INC.
Vermögen: - $ am 31.03.2024
Profil
Steven P.
Cobourn is currently the Chief Financial & Accounting Officer at NextCure, Inc. Prior to his current position, he served as the Chief Financial Officer at Vaccinex, Inc. from 2014 to 2018.
Before that, he held the position of Vice President-Finance & Treasurer at Otsuka America Pharmaceutical, Inc. from 2003 to 2014.
Mr. Cobourn completed his undergraduate degree at Drexel University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
NEXTCURE, INC.
-.--% | 29.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Steven Cobourn
Unternehmen | Position | Beginn |
---|---|---|
NEXTCURE, INC. | Director of Finance/CFO | 01.01.2018 |
Ehemalige bekannte Positionen von Steven Cobourn
Unternehmen | Position | Ende |
---|---|---|
VACCINEXPAR | Director of Finance/CFO | 01.01.2018 |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Director of Finance/CFO | 01.04.2014 |
Ausbildung von Steven Cobourn
Drexel University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
VACCINEXPAR | Health Technology |
NEXTCURE, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |